s,n,n'-tripropylthiocarbamate has been researched along with Adenocarcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Koshy, M; Spiotto, MT | 1 |
Docherty, NG; Elliott, JA; Goldstone, AP; Healy, ML; le Roux, CW; McMorrow, JP; Moran, B; Murphy, CF; Ravi, N; Reynolds, JV; Stratford, N | 1 |
Andrews, R; Hanson, J; Kaza, A; Mojtahed, A | 1 |
1 trial(s) available for s,n,n'-tripropylthiocarbamate and Adenocarcinoma
Article | Year |
---|---|
A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
Topics: Adenocarcinoma; Aged; Brain; Delayed-Action Preparations; Esophageal Neoplasms; Esophagectomy; Feasibility Studies; Female; Gastrointestinal Hormones; Gastrointestinal Tract; Humans; Male; Middle Aged; Octreotide; Pilot Projects; Postoperative Complications; Postprandial Period; Reward; Satiety Response; Signal Transduction; Wasting Syndrome; Weight Loss | 2021 |
2 other study(ies) available for s,n,n'-tripropylthiocarbamate and Adenocarcinoma
Article | Year |
---|---|
The Risk Is Worth the Reward: Regional-Only Recurrence Is Curable with Nodal Dissection.
Topics: Adenocarcinoma; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Prostate; Reward | 2020 |
Rewards of Persistence: Manometric Clues to Cancer.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Humans; Male; Manometry; Reward | 2016 |